福安药业子公司收到一项化学原料药上市申请批准

Core Viewpoint - The company, Fu'an Pharmaceutical, has received approval from the National Medical Products Administration for the market launch of the chemical raw material drug, Metronidazole, which is primarily used to treat infections caused by anaerobic bacteria [1] Group 1 - Fu'an Pharmaceutical's wholly-owned subsidiary, Ningbo Tianheng Pharmaceutical Co., Ltd., has been granted the approval notice for the market application of Metronidazole [1] - Metronidazole is indicated for the treatment of infectious diseases caused by anaerobic bacteria, including lower respiratory tract infections, pelvic inflammatory disease, and sepsis [1]